CORC  > 中南大学
Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2
Ning, Cheng-Qing; Lu, Cheng; Hu, Liang; Bi, Yan-Jing; Yao, Lei; He, Yu-Jun; Liu, Li-Fei; Liu, Xiao-Yu; Yu, Nie-Fang*
刊名European Journal of Medicinal Chemistry
2015
卷号95页码:104-115
关键词Histone deacetylase FLT3 JAK2 Macrocyclic Multi-target inhibitor
ISSN号0223-5234
DOI10.1016/j.ejmech.2015.03.034
URL标识查看原文
WOS记录号WOS:000354139900010
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3325034
专题中南大学
作者单位1.[Liu, Xiao-Yu
2.Yu, Nie-Fang
3.Lu, Cheng
4.Bi, Yan-Jing
5.Liu, Li-Fei
6.Hu, Liang
7.He, Yu-Jun
8.Ning, Cheng-Qing
9.Yao, Lei] Cent S Univ, Sch Pharmaceut Sci, Changsha 410013, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Ning, Cheng-Qing,Lu, Cheng,Hu, Liang,et al. Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2[J]. European Journal of Medicinal Chemistry,2015,95:104-115.
APA Ning, Cheng-Qing.,Lu, Cheng.,Hu, Liang.,Bi, Yan-Jing.,Yao, Lei.,...&Yu, Nie-Fang*.(2015).Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2.European Journal of Medicinal Chemistry,95,104-115.
MLA Ning, Cheng-Qing,et al."Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2".European Journal of Medicinal Chemistry 95(2015):104-115.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace